全球药讯  

World Preview 2015, Outlook to 2020（Ⅳ）

出　　处：《药学进展》2015年第11期855-869,共15页Progress in Pharmaceutical Sciences

摘　　要：随着全球医药产业格局的迅速变化，中国药企创新和国际化的快速发展，数据信息已然成为新时期激活中国医药产业经济发展的引擎，实现产业转型升级的重要战略工具。灵麦医药（Lingmed）作为世界著名医药研发预估数据提供商Evaluate在中国的独家合作伙伴,为中国药企带来最专业的全球医药市场预估和分析。The eighth edition of Evaluate Pharma＇s World Preview brings together many of our analyses to provide a top level insight, from the world＇s financial markets, into the expected performance of the industry between now and 2020. Based on Evaluate Pharma＇s coverage of the world＇s leading 5,000 pharmaceutical and biotech companies, the World Preview highlights trends in prescription drug sales, patent risk, RD spend, global brand sales and market performance by therapy area. Also included in the report is a brief review of 2014 performance.

关 键 词：中国医药产业 数据信息 中国药 经济发展 产业转型 合作伙伴 医药研发 医药市场 

分 类 号：R94[医药卫生—药剂学]